09.11.19
Tel Aviv, Israel
www.avgol.com
2019 Nonwoven Sales: $400 million
Key Personnel
David Meldram, CEO; Shachar Rachim, deputy CEO; Gilad Frenkel, vice president of sales and marketing; Soren Lian, APAC sales director; Thomas Dort, vice president of technology
Plants
Israel, North Carolina, China, Russia, India
Major Markets
Hygiene, medical
Strong growth in all sectors of the hygiene category has led to impressive growth for Avgol. The company reported 2019 sales reached $400 million and is expected to continue this upward trajectory leading to regionalized organic growth.
“We’ve had a successful year on several important fronts, maintaining our presence as a global leader in the manufacture of high performance, lightweight nonwoven fabric solutions for the hygiene market,” says director of market intelligence Nick Carter. “The proportion of lightweight material to standard has increased by a double-digit percentage and our innovative FIT platform is continuing to make developmental inroads. “
Avgol’s Waveform 3D technology, beneFIT and comfortFIT platforms have all entered development programs with a number of brands for new products in 2020-2021. While Covid-19 has led to some delays in new product development for the sector, Avgol is in a fantastic position and poised to continue this momentum including the new sales for PPE materials.
In 2018, Avgol was purchased by chemical specialties supplier Indorama Ventures Ltd, joining other companies throughout the hygiene supply chain. This has allowed Avgol to benefit from synergies between the companies.
“We also have access to highly detailed global market data, which gives us more precise analyses and projections to work from, which strengthens our offering and allows more selective avenues for product and technology development,” Carter says. “IVL’s ownership and infrastructure also gives Avgol a great deal of support in broadening out into alternative markets, where the business can use its technologies to bring high added value solutions.”
Avgol’s global nonwovens manufacturing footprint includes facilities in North Carolina, China, Russia, India and Israel. In recent years, rather than invest in large-scale production lines, the company has been enhancing existing lines to make new products with a strong focus on sustainability.
“Crucially for us, our global operations are aligned with our ‘reduce-displace-recycle’ program which reframes the discussion on sustainability in nonwovens to create hygiene solutions with a much lower environmental impact. The new capabilities being brought on-line will increase the availability of higher performance materials by region.”
In terms of end use markets, hygiene continues to be Avgol’s primary segment the global demand for medical and PPE substrates is here to stay and has required rapid flexing of Avgol assets and technologies to maximize our opportunity. Avgol is currently maintaining a low-key approach to seeking additional business in new market sectors due to its full loading for the sustainable hygiene sector and meeting the substantial incremental demands for protective components, as well as organic growth in core markets.
“Fresh thinking and technological advancement are the lifeblood of Avgol,” Carter adds. “The market doesn’t stay still for long, which means we must be just as agile and responsive in our offering.
Avgol recently launched natureFIT family of technologies as part of its FIT platform. This exemplifies its strong focus on sustainability which matches that of the consumers. The natureFIT portfolio enables more effective value-driven product development across hygiene applications, while reducing environmental impact in terms of resources and waste.
Additionally, beneFIT Defense, a nonwoven substrate technology, responds to global antimicrobial and viral control needs, which have become accelerated as the world moves towards ‘the new normal.’ Another significant step for the business is how the company approaches development of technologies. “We are collaborating much more closely with academia and new businesses arriving to the market,” he says. “We believe this synergistic development will sharpen focus and further prepare Avgol for effective NPD as we boost capacity.”
www.avgol.com
2019 Nonwoven Sales: $400 million
Key Personnel
David Meldram, CEO; Shachar Rachim, deputy CEO; Gilad Frenkel, vice president of sales and marketing; Soren Lian, APAC sales director; Thomas Dort, vice president of technology
Plants
Israel, North Carolina, China, Russia, India
Major Markets
Hygiene, medical
Strong growth in all sectors of the hygiene category has led to impressive growth for Avgol. The company reported 2019 sales reached $400 million and is expected to continue this upward trajectory leading to regionalized organic growth.
“We’ve had a successful year on several important fronts, maintaining our presence as a global leader in the manufacture of high performance, lightweight nonwoven fabric solutions for the hygiene market,” says director of market intelligence Nick Carter. “The proportion of lightweight material to standard has increased by a double-digit percentage and our innovative FIT platform is continuing to make developmental inroads. “
Avgol’s Waveform 3D technology, beneFIT and comfortFIT platforms have all entered development programs with a number of brands for new products in 2020-2021. While Covid-19 has led to some delays in new product development for the sector, Avgol is in a fantastic position and poised to continue this momentum including the new sales for PPE materials.
In 2018, Avgol was purchased by chemical specialties supplier Indorama Ventures Ltd, joining other companies throughout the hygiene supply chain. This has allowed Avgol to benefit from synergies between the companies.
“We also have access to highly detailed global market data, which gives us more precise analyses and projections to work from, which strengthens our offering and allows more selective avenues for product and technology development,” Carter says. “IVL’s ownership and infrastructure also gives Avgol a great deal of support in broadening out into alternative markets, where the business can use its technologies to bring high added value solutions.”
Avgol’s global nonwovens manufacturing footprint includes facilities in North Carolina, China, Russia, India and Israel. In recent years, rather than invest in large-scale production lines, the company has been enhancing existing lines to make new products with a strong focus on sustainability.
“Crucially for us, our global operations are aligned with our ‘reduce-displace-recycle’ program which reframes the discussion on sustainability in nonwovens to create hygiene solutions with a much lower environmental impact. The new capabilities being brought on-line will increase the availability of higher performance materials by region.”
In terms of end use markets, hygiene continues to be Avgol’s primary segment the global demand for medical and PPE substrates is here to stay and has required rapid flexing of Avgol assets and technologies to maximize our opportunity. Avgol is currently maintaining a low-key approach to seeking additional business in new market sectors due to its full loading for the sustainable hygiene sector and meeting the substantial incremental demands for protective components, as well as organic growth in core markets.
“Fresh thinking and technological advancement are the lifeblood of Avgol,” Carter adds. “The market doesn’t stay still for long, which means we must be just as agile and responsive in our offering.
Avgol recently launched natureFIT family of technologies as part of its FIT platform. This exemplifies its strong focus on sustainability which matches that of the consumers. The natureFIT portfolio enables more effective value-driven product development across hygiene applications, while reducing environmental impact in terms of resources and waste.
Additionally, beneFIT Defense, a nonwoven substrate technology, responds to global antimicrobial and viral control needs, which have become accelerated as the world moves towards ‘the new normal.’ Another significant step for the business is how the company approaches development of technologies. “We are collaborating much more closely with academia and new businesses arriving to the market,” he says. “We believe this synergistic development will sharpen focus and further prepare Avgol for effective NPD as we boost capacity.”